• 1
    Barker J Jr, Wallner K, Merrick G. Gross hematuria after prostate brachytherapy. Urology 2003; 61: 408411
  • 2
    Anderson JF, Swanson DA, Levy LB et al. Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience. Urology 2009; 74: 601605
  • 3
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2003; 56: 454461
  • 4
    Crook J, Fleshner N, Roberts C, Pond G. Long-term urinary sequelae following 125Iodine brachytherapy. J Urol 2008; 179: 141146
  • 5
    Stock RG, Stone NN. Permanent radioactive seed implantation in the treatment of prostate cancer. Hematol Oncol Clin North Am 1999; 13: 489501
  • 6
    Davis BJ, Horwiz EM, Lee WR et al. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy 2012; 11: 619
  • 7
    Roach M 3rd, Hanks G, Thames H Jr et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965974
  • 8
    Stone NN, Gerber NK, Blacksburg S, Stone J, Stock RG. Factors influencing urinary symptoms 10 years after permanent prostate seed implantation. J Urol 2012; 187: 117123
  • 9
    Kollmeier MA, Stock RG, Cesaretti J, Stone NN. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol 2005; 173: 808812
  • 10
    Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 1999; 45: 5967
  • 11
    Yoshioka Y, Nose T, Yoshida K et al. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a 10 retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys 2003; 56: 213220
  • 12
    Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol 2002; 41: 427433
  • 13
    Grossfeld GD, Litwin MS, Wolf JS Jr et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association Best Practice Policy – Part II. Patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology valuation and follow-up. Urology 2001b; 57: 604
  • 14
    Zelefsky MJ, Levin EJ, Hunt M et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008; 70: 11241129